Bridgeway Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,100
| Closed | -$33.1K | – | 1381 |
|
|
2023
Q4 | $33.1K | Hold |
14,100
| – | – | ﹤0.01% | 1332 |
|
|
2023
Q3 | $26.2K | Sell |
14,100
-250,351
| -95% | -$466K | ﹤0.01% | 1334 |
|
|
2023
Q2 | $693K | Hold |
264,451
| – | – | 0.02% | 818 |
|
|
2023
Q1 | $431K | Sell |
264,451
-100,000
| -27% | -$163K | 0.01% | 921 |
|
|
2022
Q4 | $485K | Buy |
364,451
+70,000
| +24% | +$93.1K | 0.01% | 887 |
|
|
2022
Q3 | $459K | Buy |
294,451
+151,800
| +106% | +$237K | 0.01% | 914 |
|
|
2022
Q2 | $220K | Hold |
142,651
| – | – | 0.01% | 1074 |
|
|
2022
Q1 | $365K | Sell |
142,651
-99,500
| -41% | -$255K | 0.01% | 1017 |
|
|
2021
Q4 | $710K | Sell |
242,151
-160,149
| -40% | -$470K | 0.01% | 877 |
|
|
2021
Q3 | $986K | Buy |
402,300
+174,300
| +76% | +$427K | 0.02% | 836 |
|
|
2021
Q2 | $928K | Sell |
228,000
-30,000
| -12% | -$122K | 0.02% | 885 |
|
|
2021
Q1 | $1.16M | Buy |
258,000
+109,000
| +73% | +$492K | 0.02% | 805 |
|
|
2020
Q4 | $733K | Sell |
149,000
-69,000
| -32% | -$339K | 0.02% | 827 |
|
|
2020
Q3 | $1.29M | Hold |
218,000
| – | – | 0.03% | 584 |
|
|
2020
Q2 | $580K | Buy |
218,000
+100,000
| +85% | +$266K | 0.01% | 808 |
|
|
2020
Q1 | $230K | Buy |
+118,000
| New | +$230K | 0.01% | 1014 |
|